Blood Transfusion Diagnostics Market Growth, Trends, Industry Statistics 2022-2030

The global Blood Transfusion Diagnostics market size is expected to be worth around US$ 10.8 billion by 2030, according to a new report by Vision Research Reports.

The global Blood Transfusion Diagnostics market size was valued at US$ 4,713.7 million in 2020 and is anticipated to grow at a CAGR of 7.6% during forecast period 2021 to 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38912

Report Coverage

Report Scope Details
Market Size US$ 10.8 Billion by 2030
Growth Rate CAGR of 7.6% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Product, Application, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Immucor, Inc.; Ortho Clinical Diagnostics; Abbott; Bio-Rad Laboratories; F. Hoffmann-La Roche AG; Quotient Limited; BAG Healthcare GmbH; DiaSorin S.P.A.; Danaher;BIO KIT (Werfen)

Growth Factors

This growth can be attributed to the increasing rate of approval by the U.S. FDA for blood transfusion diagnostics products. The introduction of new technologies to assist in blood donation and storage is expected to further drive the market.

Growing initiatives for blood donation campaigns is another driver boosting market growth significantly. The slogan for the.2021 was Give blood and keep the world-beating. The major focus of this year’s campaign by WHO was to encourage the young population to donate and ensure a safe blood supply. With economies are relaxing their norms and the number of blood donation campaigns across the world is increasing, the need for blood transfusion diagnostics is expected to increase to the pre-COVID-19 level.

By Product Analysis

The reagents and kits segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 65.8%. Easy availability of products and repetitive purchase of these products required to screen both donor and recipient samples have majorly driven the segment growth.

Increasing the launch of products and approvals for different systems or automated systems by key players for blood transfusion is expected to boost the market growth.

By Application Analysis

The disease screening segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 60.0% in 2020. increasing safety screening of donated blood, to maintain safe transfusion; rising technological advancements; and wide product portfolios offered by key players in the market.

The blood grouping segment is expected to hold a significant revenue share during the study period. These diagnostic tests are commonly performed in the blood banks. Routine blood typing and cross-matching tests performed before transfusion therapy for identifying the compatibility of donor and recipient blood are some of the factors driving the segmental growth.

By End-use Analysis

The blood banks segment dominated the market for blood transfusion diagnostics and accounted for the largest revenue share of 40.9% in 2020. This is due to a large number of disease screening and blood typing services performed before transfusion therapy.

It is mandatory for hospitals to screen donated blood for infections, perform compatibility tests of donor and recipient as a pretransfusion therapy, and set parameters of hematology components. Thus, the hospitals’ segment accounted for significant shares in 2020.

By Regional Analysis

 North America dominated the blood transfusion diagnostics market and accounted for the largest revenue share of 40.1% in 2020. The segment is expected to maintain its position during the forecast period. Increasing health awareness, high disposable income.

In Asia Pacific, the market for blood transfusion diagnostics is expected to grow at the fastest rate during the forecast period. the declining number of donors in Singapore and South Korea has led to less adoption of transfusion diagnostic tools in Asia Pacific.

Key Players

  • Immucor, Inc.
  • Ortho Clinical Diagnostics
  • Abbott
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche AG
  • Quotient Limited
  • BAG Healthcare GmbH
  • DiaSorin S.P.A.
  • Danaher
  • BIOKIT (Werfen)

Market Segmentation

  • By Product
    • Reagents & Kits
    • Instruments
    • Others
  • By Application
    • Blood Grouping
    • Disease Screening
      • Serological Disease Screening
      • Molecular Disease Screening
  • By End-use
    • Hospitals
    • Blood Banks
    • Diagnostic Laboratories
    • Others
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • South Korea
      • Singapore
      • Australia
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38912

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Blood Transfusion Diagnostics Market, By Product

7.1.  Blood Transfusion Diagnostics Market, by Product, 2021-2030

7.1.1.    Reagents & Kits

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Instruments

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Others

7.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Blood Transfusion Diagnostics Market, By Application

8.1.  Blood Transfusion Diagnostics Market, by Application, 2021-2030

8.1.1.    Blood Grouping

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Disease Screening

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Blood Transfusion Diagnostics Market, By End User

9.1.  Blood Transfusion Diagnostics Market, by End User, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Blood Banks

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Diagnostic Laboratories

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Others

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Blood Transfusion Diagnostics Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2017-2030)

10.1.2.  Market Revenue and Forecast, by Application (2017-2030)

10.1.3.  Market Revenue and Forecast, by End User (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2017-2030)

10.2.2.  Market Revenue and Forecast, by Application (2017-2030)

10.2.3.  Market Revenue and Forecast, by End User (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2017-2030)

10.3.2.  Market Revenue and Forecast, by Application (2017-2030)

10.3.3.  Market Revenue and Forecast, by End User (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2017-2030)

10.4.2.  Market Revenue and Forecast, by Application (2017-2030)

10.4.3.  Market Revenue and Forecast, by End User (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2017-2030)

10.5.2.  Market Revenue and Forecast, by Application (2017-2030)

10.5.3.  Market Revenue and Forecast, by End User (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2017-2030)

Chapter 11.  Company Profiles

11.1.              Immucor, Inc.

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Ortho Clinical Diagnostics

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Abbott

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Air France KLM Group

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Bio-Rad Laboratories

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              F. Hoffmann-La Roche AG

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Quotient Limited

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              BAG Healthcare GmbH

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              DiaSorin S.P.A.

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Danaher

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38912

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com